鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/10/26 | 3,710 | 3,720 | 3,620 | 3,650 | -50 | -1.4% | 31,500 |
| 2023/10/25 | 3,730 | 3,760 | 3,695 | 3,700 | -15 | -0.4% | 50,100 |
| 2023/10/24 | 3,785 | 3,790 | 3,645 | 3,715 | -80 | -2.1% | 67,000 |
| 2023/10/23 | 3,875 | 3,875 | 3,785 | 3,795 | -55 | -1.4% | 47,900 |
| 2023/10/20 | 3,870 | 3,885 | 3,830 | 3,850 | ±0 | ±0% | 17,300 |
| 2023/10/19 | 3,905 | 3,905 | 3,815 | 3,850 | -55 | -1.4% | 23,000 |
| 2023/10/18 | 3,910 | 3,925 | 3,870 | 3,905 | +5 | +0.1% | 31,200 |
| 2023/10/17 | 3,900 | 3,930 | 3,860 | 3,900 | +35 | +0.9% | 22,800 |
| 2023/10/16 | 3,870 | 3,900 | 3,835 | 3,865 | -10 | -0.3% | 36,000 |
| 2023/10/13 | 3,900 | 3,945 | 3,855 | 3,875 | -35 | -0.9% | 37,400 |
| 2023/10/12 | 3,815 | 3,925 | 3,815 | 3,910 | +100 | +2.6% | 28,300 |
| 2023/10/11 | 3,860 | 3,875 | 3,810 | 3,810 | -60 | -1.6% | 32,700 |
| 2023/10/10 | 3,875 | 3,890 | 3,780 | 3,870 | +180 | +4.9% | 76,300 |
| 2023/10/06 | 3,660 | 3,725 | 3,655 | 3,690 | +35 | +1% | 22,000 |
| 2023/10/05 | 3,570 | 3,660 | 3,570 | 3,655 | +55 | +1.5% | 35,100 |
| 2023/10/04 | 3,650 | 3,680 | 3,580 | 3,600 | -90 | -2.4% | 70,400 |
| 2023/10/03 | 3,800 | 3,805 | 3,680 | 3,690 | -115 | -3% | 47,800 |
| 2023/10/02 | 3,930 | 3,935 | 3,805 | 3,805 | -65 | -1.7% | 19,300 |
| 2023/09/29 | 3,960 | 3,960 | 3,865 | 3,870 | -90 | -2.3% | 36,700 |
| 2023/09/28 | 3,950 | 3,985 | 3,920 | 3,960 | +10 | +0.3% | 52,400 |
| 2023/09/27 | 3,900 | 3,980 | 3,865 | 3,950 | +30 | +0.8% | 51,300 |
| 2023/09/26 | 3,875 | 3,935 | 3,865 | 3,920 | -5 | -0.1% | 15,300 |
| 2023/09/25 | 3,855 | 3,935 | 3,850 | 3,925 | +110 | +2.9% | 29,500 |
| 2023/09/22 | 3,800 | 3,840 | 3,790 | 3,815 | +15 | +0.4% | 26,200 |
| 2023/09/21 | 3,785 | 3,855 | 3,785 | 3,800 | -10 | -0.3% | 16,700 |
| 2023/09/20 | 3,840 | 3,850 | 3,790 | 3,810 | -50 | -1.3% | 16,900 |
| 2023/09/19 | 3,870 | 3,885 | 3,830 | 3,860 | ±0 | ±0% | 16,300 |
| 2023/09/15 | 3,805 | 3,870 | 3,765 | 3,860 | +95 | +2.5% | 20,700 |
| 2023/09/14 | 3,795 | 3,795 | 3,710 | 3,765 | -35 | -0.9% | 19,300 |
| 2023/09/13 | 3,850 | 3,860 | 3,800 | 3,800 | -50 | -1.3% | 13,100 |
| 2023/09/12 | 3,790 | 3,855 | 3,780 | 3,850 | +80 | +2.1% | 15,400 |
| 2023/09/11 | 3,770 | 3,795 | 3,755 | 3,770 | +25 | +0.7% | 11,500 |
| 2023/09/08 | 3,715 | 3,765 | 3,715 | 3,745 | +10 | +0.3% | 20,900 |
| 2023/09/07 | 3,730 | 3,760 | 3,725 | 3,735 | -20 | -0.5% | 15,600 |
| 2023/09/06 | 3,770 | 3,770 | 3,720 | 3,755 | -40 | -1.1% | 20,700 |
| 2023/09/05 | 3,780 | 3,800 | 3,770 | 3,795 | +5 | +0.1% | 12,500 |
| 2023/09/04 | 3,830 | 3,830 | 3,770 | 3,790 | -10 | -0.3% | 25,400 |
| 2023/09/01 | 3,755 | 3,830 | 3,755 | 3,800 | +45 | +1.2% | 22,200 |
| 2023/08/31 | 3,750 | 3,765 | 3,700 | 3,755 | -35 | -0.9% | 27,700 |
| 2023/08/30 | 3,825 | 3,835 | 3,780 | 3,790 | -35 | -0.9% | 14,800 |
| 2023/08/29 | 3,765 | 3,825 | 3,765 | 3,825 | +40 | +1.1% | 19,300 |
| 2023/08/28 | 3,750 | 3,810 | 3,750 | 3,785 | +40 | +1.1% | 15,700 |
| 2023/08/25 | 3,670 | 3,750 | 3,665 | 3,745 | +45 | +1.2% | 21,200 |
| 2023/08/24 | 3,650 | 3,725 | 3,650 | 3,700 | +55 | +1.5% | 22,600 |
| 2023/08/23 | 3,615 | 3,650 | 3,615 | 3,645 | -5 | -0.1% | 11,200 |
| 2023/08/22 | 3,605 | 3,655 | 3,605 | 3,650 | +35 | +1% | 10,800 |
| 2023/08/21 | 3,565 | 3,635 | 3,565 | 3,615 | +10 | +0.3% | 9,000 |
| 2023/08/18 | 3,610 | 3,640 | 3,585 | 3,605 | -5 | -0.1% | 15,300 |
| 2023/08/17 | 3,610 | 3,610 | 3,565 | 3,610 | +10 | +0.3% | 13,600 |
| 2023/08/16 | 3,620 | 3,645 | 3,590 | 3,600 | -50 | -1.4% | 22,400 |
351～
400
件表示中 / 3673件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 416,000円 | +7.1% | -35.0% | 2.88% | 34.40倍 | 0.96倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| キッセイ薬 | 365,000円 | +14.5% | -2.3% | 2.47% | 13.35倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 237,600円 | +15.0% | -7.3% | 2.95% | 7.79倍 | 0.73倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 214,300円 | +14.2% | +41.0% | 2.15% | 10.50倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| サンバイオ | 141,200円 | - | - | 0.00% | - | 65.40倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
